Page 208 - Eshre Final Programme 2015
P. 208
POSTERS Endometriosis/endometrium
P-311 Predictability of frequency of uterine contractions in the early luteal phase after controlled ovarian stimulation in non-progesterone supplemented oocyte donors
B.M. Klein1, L. Helmgaard2, J.C. Arce2
1Ferring Pharmaceuticals, Global Clinical R&D (Biometrics), Copenhagen, Denmark
2Ferring Pharmaceuticals, Global Clinical R&D (Reproductive Health), Copenhagen, Denmark
P-312 Predictability of frequency of uterine contractions in the early luteal phase after controlled ovarian stimulation in progesterone-supplemented oocyte donors
L. Helmgaard1, B.M. Klein2, J.C. Arce1
1Ferring Pharmaceuticals, Global Clinical R&D (Reproductive Health), Copenhagen, Denmark 2Ferring Pharmaceuticals, Global Clinical R&D (Biometrics), Copenhagen, Denmark
P-313 Endometrial growth inhibition by natural compounds evaluated as new therapeutic agents for endometriosis
L. Ferella1, J.I. Baston1, M. Bilotas2, J.J. Singla3, A.M. Gonzalez4, C. Olivares1, G.F. Meresman1
1Instituto de Bilogia y Medicina Experimental, Laboratorio de fisiopatologia endometrial, Buenos Aires, Argentina
2Instituto de Bilogia y Medicina Experimental, Laboratorio de inmunología en reproducción, Buenos Aires, Argentina
3Hospital de Clinicas, Servicio de ginecología, Buenos Aires, Argentina 4Hospital Naval, Servicio de ginecología, Buenos Aires, Argentina
P-314 Imbalance Progesterone Receptor-A/-B ratio via +331G/A polymorphism enhance MMP-2, -9 expression in endometriosis
S. Mousazadeh1, P. Afsharian1, M. Shahhoseini1, R.E.Z.A. Aflatoonian2
1Royan Institute, Department of Genetics at Reproductive Biomedicine Research Center ACECR, Tehran, Iran
2Royan Institute, Department of Endocrinology and Female Infertility at Reproductive Biomedicine Research Center Royan Institute for Reproductive Biomedicine ACECR, Tehran, Iran
P-315 Endometrioma and Artificial Reproductive Techniques (ART) outcomes: Results from Meta- Analysis and Systematic review
Y. Cheong1, M. Hamdan1, G.D. Dunselman2, T.C. Li3
1Complete Fertility Centre Princess Anne Hospital, Human Development and Health, Southampton, United Kingdom
2Research Institute GROW, Obstetrics and Gynaecology, Maastricht, The Netherlands
3The Chinese University of Hong Kong, Obstetrics and Gynaecology, Hong Kong, Hong Kong
208
